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Here we report that hone morphogenetic proteins 2 and 3 (BMP-2 and BMP-3) induced marked expression of c-fix mRNA in a biphasic manner, 
i.e. the late phase (48 to 60 II) as well as the immediate-early phase (0.5 h), in murine osteoblastic MC3T3-El cells in vitro. The BMP-induced late 
phase c-&s gene expression was temporally associated with the onset of marked expression of the genes for osteocalcin and alkaline phosphatase, 
dil’fcrentiatian markers of mature osteoblasts. In contrast, none ofTGF#I, 10% FBS, IGF-I and IGF-II, which induced only the immediate-early 
c-fos mRNA expression, stimulated the expression or osteocalcin and alkaline phosphatase pcncs. These data suggest that in ostcoblasts DMP-2 
and BMP-3 induce the late phase expression of c-fos, which may play n role in transcriptional activation of the genes involved in differentiation 
of ostcoblasts. 
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1. INTRODUCTlON 
Expression of the proto-onsogene c-fos is known to 
be associated with such diverse biological processes as 
proliferation [l-S], cellular transformation [6], and dif- 
ferentiation [7-g]. Previous studies have shown that the 
expression of c-fos is differentiation stage-, tissue- and 
cell type-specific and occurs in a sustained manner in 
cells constituting the amnion and placenta [lo], bone 
marrow [ 1 l], and differentiated macrophages [11,121, 
suggesting a close association of c-fos and cellular dif- 
ferentiation [l l-14]. Moreover, the expression of ex- 
ogenously introduced c-fos gene triggers cellular differ- 
entiation in F9 teratocarcinoma stem cells [7]. These 
lines of evidence suggest hat c-fos is involved in the 
induction of differentiation at least in some cell types. 
We have previously shown that c-fos is expressed in 
a sustained manner in vivo in osteoblasts in the ossify- 
ing fracture calluses of adult rat long bones. The sus- 
tained expression oft-fbs is associated with the sequen- 
tial expression of the genes for alkaline phosphatase, 
osteopontin, and osteocalcin, that are differentiation 
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markers of osteoblasts. These observations have led us 
to hypothesize that the sustained expression of c-jbs 
may have a role in the induction of osteoblastic differen- 
tiation [15]. Since the expression of c-fos is caused 
mostly by external signals [16-l S], it is conceivable that 
the sustained c-fos expression in osteoblasts in the frac- 
ture calluses is elicited by some external signals trans- 
ferred via fracture-triggered liberation of cytokine(s) 
such as bone morphogenetic proteins (BMPs) [19,20-j, 
transforming rowth factor ps (TGF-,&) [21], and insu- 
lin-like growth factors (IGFs) [22-251. 
BMPs refer to an activity derived from bone that 
induces formation of cartilage and bone in vivo [20]. 
BMPs are also likely to play an important role in frac- 
ture healing processes [26,27]. We and others recently 
showed that BMPs are involved not only in the differen- 
tiation of uncommitted mesenchymal cells to cells of 
chondrocytic and osteoblastic lineage but also in the 
differentiation of immature osteoblasts into mature os- 
teoblasts [28-321. 
In the present study we examined the effects of puri- 
fiqd BMPs and other cytokines on the expression of 
c-fis and osteoblastic marker genes in the murine os- 
teoblastic MC3T3-El cells in vitro. We show here that: 
(1) BMPs i=dtice persiste!?t c-$os mRNA. expression in 
the late phase as well as the immediate-early phase; and 
(2) the late phase c-fos expression is persistent and par- 
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all&d by marked expression of osteoblastic differentia- 
tion-related genes. 
2. MATERIALS AND METHODS 
2.1. Matrrials 
Bone morphogcnetic proteins were prepared from an ostcoinductive 
fraction of 4 M poanidine-HCI extracts ofdcmineralized bovine bone 
matrix and finally separated from contaminating osteoglycin by re- 
versed-phase high-performance liquid chromatography as described 
in dctiiil elsewhere [33,34]. Our preparation of bone morphogcnetic 
proteins (BMPs) is a mixture of BMP-2 and BMP-3 at their relative 
amounts of 1:2 without other contaminants as analyzed by sodium 
dodecyl sulfate-polyacrylamide g l clcctrophoresis in both non-rcduc- 
ing nnd reducing conditions and amino acid sequence analysis of the 
peptides prepared by endopeptidase digestion, as described previously 
[32]. Osteoglycin did not have any effect on the expression of the genes 
in MC3T3-El cells analyzed in the present study (data not shown). 
The lyophilized BMPs were dissolved in phosphate-buIrered saline 
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Fig. I. Time course of c-$x mRNA expression in quiescent MC3T3- 
El cells induced by BMDs, TOF-/?I, FBS, IGF-I. and IGF-II. Cells 
were cultured as described in Materials and Methods. In (A), conflu- 
ent quiescent cells were incubated for the indicated periods (h) with 
10 n&ml BMPs. In (B), the cells were incubated with 10 n&/ml IGF-I 
or IGF-II. In (C), the cells were incubated with 1 ngfml TGF-fil or 
10% FBS. Total RNA samples were prepared and aliquots (20 ,ud 
lane) were electrophoresed in 1% agarose gel, transblotted to a nylon 
membrane, hybridird with u 3’P-iabeied V-&S fDNA fragment and 
autoradiographcd. The integrity of the RNA was confirmed by ethid- 
ium bromide Skiining, as shown below each lane The positions of 28 
S and 18 S ribosomal RNA are indicated. 
A clanal cell line, MC3T3-El, derived from newborn mouse cal- 
varia was a generous Sift from Dr. H. Kodama (Ohu Dental College, 
Kohriyama, Japan). These cells display several phenotyps character- 
istic of immature osteoblasts and can diffcrcntiatc into mature osteob- 
lasts in prolonged sulture [36-381. Cells were maintained in aMEM 
containing 3% FDS at 37*C in a humidified atmosphere of 5% CO2 
in air, with regular subculture very 3 days. ConRucnt cells were rinsed 
once with aMEM containiag 0.3% FBS and incubated for 24 h in the 
same medium before the test substauces were added. Cells were further 
incubated for the varying priods of time as indicated. 
IGF-I IGF-II 
I 
0.5 24 48 60 A.5 24 48 $a (h) 
0.5 24 48 60 
containing 0.1% BSA (Cnlbiochcm, CA). Bovine bone-derived tnns- 
forming growth factor-b1 (TGF-PI) was purified as described [35]. 
IGF-1 and IGF-II wcrc purchased from KabiGcn AB (Stockholm, 
Sweden). Alpha modification of minimum essential medium (aMEM) 
was purchased from Irvine Scientific (Santa Ana, CA, USA). Fetal 
bovine serum (FBS) was obtained from Bioproducts (Walkersville, 
MD). Other materials used were commercial products of the highest 
grade available. 
2.2. Crll culr11re 
rc_ c-fos 
S-Q 
-28s 
-185 
10% FCS 
0.5 24 48 60 d.s24 (h) 
0.5 24 48 60 (h) 
-28s 
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2.3, Torul RN/l exrrucriotl ~tld Nortircrrr b/or mul.~~sis 
Total RNA was cxtrxtcd by Ihe acid guanidinium-phenol-chloro- 
form method [39]. Denatured total RNA (20 mg) was sepnrnted by 1% 
agarose gel clectrophoresis and transferred IO a nylon membrane 
(BioTrace, Ann Arbor, MI). Hybridization was performed at high 
stringency [IS]. The membrune was exposed lo Kodak X-Omet film 
at -80% for 24 h with a Croncx Lightning Plus intensifying screen 
(DuPont, Wilminglon, DE). The following hybridization probes were 
used: v-foes, a 1 kb Purl fragment of pv-fos-l [40]; purilied synthetic 
oligonucluotides of 50-mer corresponding to Ile”‘b-Ala’*~ (human/rat 
conscrvcd region) of rat liver/bone/kidney alkaline phosphatasc 
cDNA [4I] and of Sl-mer corresponding 10 the Cy~‘-Lys’~ of mouse 
osteocalcin cDNA [42]. The v-$x cDNA was labeled with (a-3zP)- 
dCTP (New England Nuclear, Boston, MA) using a commercially 
available random primed labeling kit (Amcrshsm, Tokyo, Japan) and 
the oligonucleotides were end-labeled with [.f-“!P]ATP (New Englund 
Nuclear, Boston, MA). 
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3. RESULTS AND DISCUSSION 0.5 24 48 60 0.5 2448 60 (h) 
The quiescent MC3T3-El cells were stimulated by 
BMPs, TGF-PI, IGF-I, IGF-II or FBS, and the time- 
course of the c-fos mRNA level was monitored by 
Northern blot hybridization. Intriguingly, BMPs (10 
ng/ml) induced expression of the c-fos gene in a biphasic 
fashion (Fig. 1A): BMPs stimulated the immediate- 
early expression of c-fos rnRNA which was character- 
ized by a rapid and transient increase within half an 
hour in the mRNA level. Expression of the C-SOS mRNA 
became undetectable by one hour after stimulation. 
After a long cessation, abundant expression of c-fos 
mRNA became once again detectable by 48 h after 
stimulation and persisted at least for an additional 12 
h. Fig. 1B and C show that, IGF-I (10 @ml), IGF-II 
(10 r&ml), TGF-b, (1 ng/ml) and 10% FBS all induced 
the immediate-early expression of c-fis mRNA. Merri- 
man et al. recently reported that IGF-I and IGF-II 
stimulated the immediate-early c-fos mRNA expression 
in osteoblasts which preceded cellular proliferation [43], 
corroborating the generally accepted concept that the 
immediate early expression of the c-&s gene is related 
to growth-response of the cells. Unlike this early phase 
c-fos expression, however, the late phase expression of 
c-fbs in osteoblasts in our study was BMPs-specific. 
6.5 2448 60 0.5 24 48 60 (h) 
Recent data indicate that BMPs induce differentia- 
tion of osteoblast precursor cells into mature osteo- 
blasts [28-321. Indeed, BMPs were able to induce 
marked expression of osteocnlcin mRNA 48-60 h after 
exposure in MC3T3-El cells (Fig. 2). Moreover, the 
expression of osteocalcin mRNA closely paralleled the 
late phase c-fos expression (Fig. 1A). None of TGF-/?I, 
IGF-I, IGF-II and 10% FBS were able to stimulate 
expression of osteocalcin mRNA (Fig. 2). BMPs are the 
rnost potent stimulator of alkaline phosphatase activity 
in MC3T3-El cells among the cytokines so far tested 
[32]. Fig. 3 shows that BMPs enhanced expression of 
a!ka!ine phosphalr,se mRNA chic!? agair! paralleled the 
late phase c-fos expression. In contrast, TGF-,& sup 
pressed the expression of alkaline phosphatase mRNA, 
confirming our previous observations that TGF-pl, as 
Fig. 2. Time course OF osteoculcin mRNA expression in quiescent 
MC3T3sEI cells induced by BMPs, TGF-PI, FBS, IGF-I, and IGF-Il. 
The membrane shown in Fig. I was dchybridized, and then rehybr- 
idized with the radiolabeled probe for osteocalcin mRNA. The posi- 
lions of 28 S and 18 S ribosomal RNA arc indicated. 
well as FBS, suppressed the alkaline phosphatase activ- 
ity while it stimulated the cellular proliferation of 
MC3T3- El cells [32&l]. Thus, BMPs induced the late 
phase c-fis expression which was temporally associated 
with the marked expression of osteoblastic marker 
genes in MC3T3-El cells. Our results provide in vitro 
evidence 
for the hypothesis that the sustained late phase expres- 
sion of the c-fos gene plays a role in osteoblastic differ- 
entiation. 
Gonda et al. showed that grnnulocyte-colony stimu- 
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Fig. 3. Alkaline phosphatasc (ALP) mRNA expression in quicsccnt 
MC3T3-El cells induced by BMPs and TGF-@I. Cells were cullwed 
and incubated as described in the legend to Fig. 1. Northern blot 
hybridizction with the radiolabeled probe for alkaline phosphatase 
mRNA was carried out as described in Materials and Methods. The 
integrity of the RNA analyzed was confirmed by cthidium bromide 
staining, as shown below each lane. The poshions of25 fi and I8 S 
ribosomal RNA are indicated. 
lating factor (G-CSF) induces the expression of c-fos at 
the late stages of differentiation (more than 49 h after 
G-CSF treatment) in murine myelomonocytic precursor 
cells [12]. Differentiation of cultured monomyelocytic 
cells is so far the only in vitro model where the C-$X gene 
is constitutively turned on [13,14]. Mitchel et al. subse- 
quently reported that the c-fos expression is neither suf- 
ficient nor obligatory for differentiation of monomyelo- 
cytes to macrophages, uggesting that one possible role 
of the fos gene product during the differentiation may 
be to signal growth arrest of cells so that they can enter 
the macrophage differentiation pathway [45]. 
It is not known whether the BMP-induced late phase 
expression of the c-fus gene in osteoblastic MC3T3-El 
cells is a step necessary to induction of the osteoblastic 
marker genes. However, the following in vivo evidence 
suggests aspecific role of the c-10s gene in bone develop- 
ment: (1) deregulated over-expression of the c-$-us gene 
in transgenic mice results in multiple lesions of in- 
creased bone formation in newborns without apparent 
abnormalities in the other tissues [46]; (2) expression of 
c-jbs mRNA is observed in the growth regions of fetal 
bone and mesodermal web tissue which are the sites of 
major changes in the orientation of fingers and toes 1471; 
and (3) as we previously reported [IS], the ossifying soft 
callus and periosteal hard callus markedly express c-fis 
mRNA in a sustained manner at the fracture site of 
adult rat tibiae in vivo. This persistent c+s expression 
was temporally followed by sequential expression of the 
genes for alkaline phosphatase, osteopontin and osteo- 
calcin in each type of fracture calluses. Further, BMPs 
are thought to play an important local regulatory role 
in fracture healing [2G,273. Taken together, it is conceiv- 
able that BMPs induce the sonstitutive expression of 
c-&s gene in committed immature osteoblasts which 
then confers on these cells the ability to pass through a 
predetermined ifferentiation pathway, by inducing the 
expression of a particular set of genes. 
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